ERA PerMed 2018 - ERA NET Co-fund Personalised Medicine
Data solutions based on a basket prospective trial with pembrolizumab and Vorinostat in patients with advanced and/or recurrent squamous cell carcinoma – PEVO data
Project coordination
Christophe LE TOURNEAU (INSTITUT CURIE SECTION MEDICALE)
The author of this summary is the project coordinator, who is responsible for the content of this summary. The ANR declines any responsibility as for its contents.
Partner
UNICANCER
INSTITUT CURIE SECTION MEDICALE
Help of the ANR 1,543,612 euros
Beginning and duration of the scientific project:
June 2019
- 36 Months
